Skip to main content

Day: January 24, 2022

Greene County Bancorp, Inc. Reports $14.0 Million in Net Income for the Six Months Ended December 31, 2021 and Total Securities Cross the $1 Billion Threshold

CATSKILL, N.Y., Jan. 24, 2022 (GLOBE NEWSWIRE) — Greene County Bancorp, Inc. (the “Company”) (NASDAQ: GCBC), the holding company for The Bank of Greene County and its subsidiary Greene County Commercial Bank, today reported net income for the three and six months ended December 31, 2021, which is the second quarter of the Company’s fiscal year ending June 30, 2022. Net income for the three and six months ended December 31, 2021 was $6.9 million, or $0.81 per basic and diluted share, and $14.0 million, or $1.64 per basic and diluted share, respectively, as compared to $6.2 million, or $0.73 per basic and diluted share, and $11.1 million, or $1.30 per basic and diluted share, for the three and six months ended December 31, 2020, respectively. Highlights:Net Income: $14.0 million for the six months ended December 31, 2021 Total...

Continue reading

Tiziana Life Sciences Ltd. To Implement Stock Repurchase Program for up to $5 Million

NEW YORK, Jan. 24, 2022 (GLOBE NEWSWIRE) — Tiziana Life Sciences Ltd. (Nasdaq: TLSA) announced that its Board of Directors has today authorized the Company’s management to implement a stock repurchase program for up to $5 million of the Company’s common shares at any time. The term of the board authorization is until December 31, 2022. The repurchase program may be suspended or discontinued at any time and will be funded using the Company’s working capital. Executive Chairman Gabriele Cerrone commented, “This announcement demonstrates our confidence in Tiziana’s business and the growth opportunities we see over the long term. We believe this is an attractive use of capital, and based on the strength of our balance sheet, we continue to see ample opportunity to invest and grow our business.” About Tiziana Life Sciences Tiziana Life...

Continue reading

The Lancet publishes studies showing Roche’s faricimab improved and maintained vision in two leading causes of vision loss, extending time between treatments up to four months

Two papers in The Lancet highlight one-year results from Roche’s phase III trials evaluating faricimab in neovascular or “wet” age-related macular (nAMD) and diabetic macular edema (DME) Across four studies, about half of eligible faricimab patients were able to go four months between treatments, and approximately three-quarters could be treated every three months or longer Reductions in central subfield thickness (CST) and resolution of intraretinal fluid consistently favoured faricimab over aflibercept in DME, and meaningful and comparable CST reductions were seen in nAMD in the first yearBasel, 24 January 2022 – Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that The Lancet has published two papers highlighting one-year results from four pivotal phase III studies of faricimab, an investigational bispecific antibody, in...

Continue reading

Flex LNG – Invitation to Q4 2021 presentation and webcast

Hamilton, BermudaJanuary 24, 2021 Flex LNG Ltd. (“Flex LNG” or the “Company”) will release its preliminary financial results for the fourth quarter of 2021 on Wednesday February 16, 2022 on or about 07:00 CET (1:00 a.m. EST). In connection with the earnings release, a webcast and conference call will be held at 15:00 CET (9:00 a.m. EST) the same day. In order to attend the webcast and/or conference call you may do one of the following: Attend by Webcast:Use to the follow link prior to the webcast: https://edge.media-server.com/mmc/p/42dfa2a2 Attend by Conference Call: Applicable dial-in telephone numbers are as follows: Norway: +47 21 56 30 15United Kingdom: +44 (0) 2071 928 338United Kingdom, local: 08444 819 752United Kingdom (toll free): 0800 279 6619United States: +1 646 741 3167United States (toll free): +1 877...

Continue reading

CEA Industries Inc. Announces Ticker Symbol Change to “CEAD” on OTCQB Exchange

Effective at the Open of Market Trading Today, The Company Began Trading as CEA Industries Inc. (OTCQB: CEAD) Louisville, Colorado, Jan. 24, 2022 (GLOBE NEWSWIRE) — CEA Industries Inc. (the “Company”) (OTCQB: CEAD), a leader in controlled environment agriculture (CEA) systems engineering and technologies, announced that at the open of market trading today, January 24, 2022, its trading name on the OTCQB stock exchange changed from “Surna Inc.” to “CEA Industries Inc.”, and its ticker symbol changed from “SRNA” to “CEAD”. This accompanies the previously reported corporate name change from Surna Inc. to CEA Industries Inc. CEA Industries’ Chairman and CEO Tony McDonald, said, “In 2021, we announced an aggressive long-term growth strategy. Moving to a new stock ticker is a reflection of the progress we have made, as it further establishes...

Continue reading

Timbercreek Financial Declares January 2022 Dividend

TORONTO, Jan. 24, 2022 (GLOBE NEWSWIRE) — Timbercreek Financial (TSX: TF) (the “Company”) is pleased to announce that it has declared a monthly cash dividend of $0.0575 per common share (“Common Share”) of the Company to be paid on February 15, 2022 to holders of Common Shares of record on January 31, 2022. The Company also offers a Dividend Reinvestment Plan (the “Plan”), which is eligible to holders of Common Shares and provides a convenient means to purchase additional Common Shares by reinvesting cash dividends at a potential discount and without having to pay commissions, service charges or brokerage fees. Pursuant to the Plan and at the discretion of Timbercreek Capital Inc., the Manager, Common Shares will be acquired in the open market at prevailing prices or issued from treasury at 98 percent of the average market price...

Continue reading

Mydecine Partners with Combat Stress to Treat Post-Traumatic Stress Disorder in Veterans

Study further supports the expansion of clinical trials of MYCO-001 for the treatment of PTSD among the Veteran population DENVER, Jan. 24, 2022 (GLOBE NEWSWIRE) — Mydecine Innovations Group (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA) (“Mydecine” or the “Company”), a biotechnology and digital technology company aiming to transform the treatment of mental health and addiction disorders, today announced a partnership with Combat Stress (Combat Stress) and the King’s College London to utilize psilocybin as part of a psychoactive-assisted psychotherapy treatment for post-traumatic stress disorder (PTSD) in veterans. Combat Stress will be one of several sites for Mydecine’s upcoming clinical trials. Combat Stress is the leading charity aiding veterans’ mental health in the United Kingdom, providing treatment and support to former servicemen...

Continue reading

Gaming Market Size Moving Upwards to Hit USD 545.98 Billion by 2028 | Global Gaming Industry Share, & Heightening Vision in Games Sector; Fortune Business Insights™

Companies covered in the gaming market are Microsoft Corporation (Redmond, Washington, United States), Nintendo Co., Ltd (Kyoto, Japan), Rovio Entertainment Corporation (Espoo, Finland), Nvidia Corporation (California, United States), Valve Corporation (Washington, United States), PlayJam Ltd (London, United Kingdom), Electronic Arts Inc (California, United States), Sony Group Corporation (Tokyo, Japan), Bandai Namco Holdings Inc (Tokyo, Japan), Activision Blizzard, Inc (California, United States), and more players profiled. Pune, India, Jan. 24, 2022 (GLOBE NEWSWIRE) — According to Fortune Business Insights™, the global gaming market size is expected to gain momentum by reaching USD 545.98 billion by 2028 while exhibiting a CAGR of 13.20 % between 2021 and 2028. Fortune Business Insight, in its report titled “Gaming Market, 2021-2028.”,...

Continue reading

Frozen Food Market Expected Worth USD 185.28 Billion by 2027 | Global Frozen Food Industry Share, Segmentation, Growth and Forecast Report by Fortune Business Insights™

Companies covered in frozen food market are Tyson Foods, Inc. (Arizona, U.S.), Unilever PLC (London, U.K.), McCain Foods Limited (Toronto, Canada), Grupo Bimbo S.A.B. DE C.V. (Mexico City, Mexico), Conagra Brands Inc. (Illinois, U.S.), General Mills Inc. (Minnesota, U.S.), Wawona Frozen Foods (California, U.S.), The Kraft Heinz Company (Illinois, U.S.), Lantmannen Unibake International (Copenhagen, Denmark), The Kellogg Company (Michigan, U.S.), Nestle SA (Vevey, Switzerland), and more players profiled Pune, India, Jan. 24, 2022 (GLOBE NEWSWIRE) — The global frozen food market size is projected to reach USD 185.28 billion by 2027, exhibiting a CAGR of 3.1% during the forecast period. The growing number of urban dwellers around the world will be a leading factor propelling this market in the near future, states Fortune Business...

Continue reading

Weebit Nano demonstrates its first crossbar ReRAM arrays

Multiple potential uses, including discrete memory chips and neuromorphic computing HOD HASHARON, Israel, Jan. 24, 2022 (GLOBE NEWSWIRE) — Weebit Nano Limited (ASX:WBT; Weebit or the Company), a leading developer of next-generation memory technologies for the global semiconductor industry, is pleased to announce that together with its development partner CEA-Leti, it has demonstrated its first operational crossbar arrays, a key milestone on the Company’s path to creating discrete (stand-alone) non-volatile memory (NVM) chips. The 1T1R (one transistor one resistor) architecture used in embedded ReRAM arrays is not sufficient to support the large arrays of memory cells needed in discrete memory chips. For this reason, Weebit’s crossbar arrays were developed using a 1S1R (one selector one resistor) architecture that enables the high...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.